CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-ThalassemiaHaydar Frangoul, Selim Corbacioglu|New England Journal of Medicine|2020Cited by 1.8k
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant ResearchSally Arai, Yoshiko Atsuta, Álvaro Urbano-Ispizúa et al.|Biology of Blood and Marrow Transplantation|2014Cited by 435
Long-Term Survival and Late Effects among One-Year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic SyndromesChristine Duncan, Mohamed L. Sorror, Navneet S. Majhail et al.|Biology of Blood and Marrow Transplantation|2014Cited by 64